Ruth O’Regan

Use of Novel Combination Therapies in the Treatment of Advanced HR+/HER2- Breast Cancer.

S. Swog, Ruth O’Regan, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer

O. Mirmosayyeb, Ajay Dhakal, Sangharsha Thapa, 2024, Cancers.